PTC
HAE icon

Petrus Trust Company’s Haemonetics HAE Stock Holding History

Petrus Trust Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,441
Closed -$265K – 80
2025
Q3 		$265K Buy
+5,441
New +$337K 0.03% 53
2024
Q4 		– Sell
-6,416
Closed -$516K – 646
2024
Q3 		$516K Buy
+6,416
New +$518K 0.05% 207
2020
Q3 		– Sell
-2,661
Closed -$238K – 306
2020
Q2 		$238K Buy
+2,661
New +$269K 0.03% 129
2015
Q4 		– Sell
-254,888
Closed -$8.24M – 171
2015
Q3 		$8.24M Buy
254,888
+92,674
+57% +$3.49M 1.75% 23
2015
Q2 		$6.71M Hold
162,214
– – 1.52% 28
2015
Q1 		$7.29M Hold
162,214
– – 1.7% 25
2014
Q4 		$6.07M Buy
162,214
+21,630
+15% +$792K 1.49% 24
2014
Q3 		$4.91M Buy
+140,584
New +$5.02M 1.21% 29

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Petrus Trust Company's HAE Position: Q4 2025 in Review

Petrus Trust Company sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 5,441 shares — an estimated $265K sold.

Petrus Trust Company first reported a position in HAE in Q3 2014 and held it in 8 quarters. The position peaked at $8.24M in Q3 2015. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Petrus Trust Company reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Petrus Trust Company sold 5,441 Haemonetics shares in Q4 2025, an estimated $265K.
  • Petrus Trust Company first reported a position in Haemonetics in Q3 2014 and held it in 8 quarters.
  • Petrus Trust Company's Haemonetics position peaked at $8.24M in Q3 2015.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.